Reading Time: 4 minutes Via YouTube
Reading Time: 4 minutes

Yes, it’s that time of day again. There’s so much I could talk about today, but this one gets top billing. Sorry to be a stuck record, but this takes the biscuit.

It’s at times like these, with a global crisis in the form of a pandemic, that the world needs to pull together for a common good. This is what, you know, good people, nice people do.

Imagine if we had an alien invasion where the whole world was the target. And then imagine that Donald Trump, as President of the United States, declared he had a weapon to fill the aliens. But he claimed he had sole rights to that weapon and that no one else could access it. or perhaps at a huge cost that they would necessarily have to pay. Then imagine that he had coerced some foreign entity into giving him the blueprints for that weapon.

Welcome to 2020, folks.

The Trump administration has offered a German medical company “large sums of money” for exclusive access to a Covid-19 vaccine, German media have reported.

The German government is trying to fight off what it sees as an aggressive takeover bid by the US, the broadsheet Die Welt reports, citing German government circles.

The US president had offered the Tübingen-based biopharmaceutical company CureVac “large sums of money” to gain exclusive access to their work, wrote Die Welt.

According to an anonymous source quoted in the newspaper, Trump was doing everything to secure a vaccine against the coronavirus for the US, “but for the US only”.

The German government was reportedly offering its own financial incentives for the vaccine to stay in the country.

When approached about the report by the Guardian, the German health ministry would only confirm the accuracy of the quotes attributed to one of its spokespersons in the article.

“The federal government is very interested in vaccines and antiviral agents against the novel coronavirus being developed in Germany and Europe,” the spokesperson quoted in the original article had said. “In this regard the government is in an intensive exchange with the company CureVac.”

The German health ministry spokesperson declined the opportunity to correct any inaccuracies in Die Welt’s account.

Whether Germany wanted exclusivity, in the same way, is a crucial factor here, because the same accusation could be levelled at them. This does not seem to be the case as the German government appeared to wrangle over this in response to Trump’s administration, as Mother Jones reported, “Die Welt then reported that the United States reached out to broker an exclusive deal on the vaccine, prompting the German government to try to counter.”

Germany is seeking to keep a valuable company like this from being fully poached by Trump and America, and this is understandable, and not the same as seeking exclusive rights.

Dw.com reported:

Vaccine ‘for the whole world’

On Sunday, the head of CureVac’s biggest investor said that an exclusive contract with the US was out of the question.

“We want to develop a vaccine for the whole world and not individual countries,” the chief executive of dievini Hopp Bio Tech Holding, Christof Hettich, told the Mannheimer Morgen newspaper, echoing a similar statement in the company’s press statement.

German Health Minister Jens Spahn told German public television that a takeover was not on the cards and that the ministry “has been in good talks with the company for the last two weeks.”

A Google Translate of a Die Welt article brings up a little more detail:

The US president reportedly offers the German company a large amount to secure its work. There is talk of a billion dollars in Berlin. What is particularly problematic is that Trump is doing everything possible to get a vaccine for the United States. “But only for the USA,” says the federal government.

She is now trying to stop Trump’s actions. If it were only about the research work of the Paul Ehrlich Institute, it would not be difficult for the federal government to accomplish. Because this institute belongs to the state. The government could ban a sale at any time. But CureVac is a private company. A sales ban is only possible under special conditions.

The federal government is currently taking a different route: representatives of the Ministry of Health and the Ministry of Economy are negotiating with CureVac. “The Federal Government is very interested in the fact that vaccines and active substances against the novel coronavirus are also being developed in Germany and Europe,” confirmed a spokesman for the Ministry of Health WELT AM SONNTAG. “In this regard, the government is in intensive exchange with the company CureVac.”

Germany, it can be heard in Berlin, is trying to keep the company with financial offers. Until Friday afternoon, however, there was no agreement. CureVac itself refused to answer questions.

From the point of view of

From the point of view of government officials, the dispute extends beyond the specific individual case. Selling a company with a vital drug is a matter of national security, it says. In extreme cases, reference is made to paragraph 6 of the Schengen Borders Code.

It said: “Border controls should help combat illegal immigration and trafficking in human beings and prevent any threats to internal security, public order, public health and the international relations of the Member States.”

In some ministries, migration of scientists or research results is in fact currently assessed as a matter of public policy. A ban on the sale of companies under the Foreign Trade and Payments Act cannot be ruled out as soon as public order or security is at risk.

Other companies are also researching a corona vaccine. However, the increasing number of infected people should increase the pressure on the federal government to keep CureVac with its possible active ingredient in the country.

Which is all very nice of Trump and his cronies. Anyone would think he actually tested positive and was desperate…

(I don’t believe that. Or do I…?)


Stay in touch! Like A Tippling Philosopher on Facebook:

A Tippling Philosopher

You can also buy me a cuppa. Please… It justifies me continuing to do this!

Avatar photo

Jonathan MS Pearce

A TIPPLING PHILOSOPHER Jonathan MS Pearce is a philosopher, author, columnist, and public speaker with an interest in writing about almost anything, from skepticism to science, politics, and morality,...